Previous close | 122.72 |
Open | 122.72 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 70.00 |
Expiry date | 2025-01-17 |
Day's range | 122.72 - 122.72 |
Contract range | N/A |
Volume | |
Open interest | 2 |
With this latest approval, JNJ's Tremfya is approved for a total of three immunology indications.
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
We recently published a list of 10 Best Big-Name Stocks to Buy Right Now According to Short Sellers. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other Best Big-Name Stocks to Buy Right Now According to Short Sellers. In early April 2024, Goldman Sachs Inc.’s data revealed […]